ES2181004T3 - Composicion farmaceutica que contiene un extracto embrionario como sustancia activa y procedimiento de preparacion relativo. - Google Patents

Composicion farmaceutica que contiene un extracto embrionario como sustancia activa y procedimiento de preparacion relativo.

Info

Publication number
ES2181004T3
ES2181004T3 ES97928188T ES97928188T ES2181004T3 ES 2181004 T3 ES2181004 T3 ES 2181004T3 ES 97928188 T ES97928188 T ES 97928188T ES 97928188 T ES97928188 T ES 97928188T ES 2181004 T3 ES2181004 T3 ES 2181004T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
active substance
composition containing
preparation procedure
embryo extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97928188T
Other languages
English (en)
Inventor
Adriana Carluccio
Pier Mario Biava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2181004T3 publication Critical patent/ES2181004T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA ADECUADA PARA EL TRATAMIENTO DE LOS TUMORES Y DE OTRAS PATOLOGIAS REGULADAS POR EL ANTIONCOGENO P53 CONTIENE UN EXTRACTO EMBRIONARIO O TOMADO DEL UTERO GRAVIDO USADO COMO SUSTANCIA ACTIVA. DICHO EXTRACTO, QUE PROCEDE DE EMBRIONES O DEL UTERO, SE TOMA EN UN ESTADO ESPECIFICO DEL DESARROLLO EMBRIONARIO Y SE ESCOGE CON RELACION A LA PATOLOGIA ESPECIFICA Y EN FUNCION DE LA ESPECIE DE ORIGEN DEL EMBRION O DEL UTERO. ESTA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARADO DE DICHA COMPOSICION.
ES97928188T 1996-09-20 1997-06-12 Composicion farmaceutica que contiene un extracto embrionario como sustancia activa y procedimiento de preparacion relativo. Expired - Lifetime ES2181004T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001945A IT1284571B1 (it) 1996-09-20 1996-09-20 Composizione antitumorale contenente come sostanza attiva un estratto embrionale o di utero gravido e relativo procedimento di preparazione

Publications (1)

Publication Number Publication Date
ES2181004T3 true ES2181004T3 (es) 2003-02-16

Family

ID=11374912

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97928188T Expired - Lifetime ES2181004T3 (es) 1996-09-20 1997-06-12 Composicion farmaceutica que contiene un extracto embrionario como sustancia activa y procedimiento de preparacion relativo.

Country Status (7)

Country Link
EP (1) EP0929308B1 (es)
AT (1) ATE222499T1 (es)
AU (1) AU3258097A (es)
DE (1) DE69714856T2 (es)
ES (1) ES2181004T3 (es)
IT (1) IT1284571B1 (es)
WO (1) WO1998011905A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003301B1 (ru) * 2000-04-28 2003-04-24 Научно-Производственное Республиканское Унитарное Предприятие "Диалек" Способ получения лекарственного средства из ткани мозга эмбрионов животного и фармакологическая композиция на его основе
RU2224528C2 (ru) * 2001-07-24 2004-02-27 Брянский государственный университет им. акад. И.Г. Петровского Способ получения биологически активных пептидов каудальной нейросекреторной системы (кнсс) позвоночных
WO2003063883A1 (fr) * 2002-01-30 2003-08-07 Airumiyan, Asmik Vardgesovna Modulateur antitumoral embryonnaire de mkrtchian, procede de fabrication et d'application
ITMI20021362A1 (it) * 2002-06-20 2003-12-22 Biava Pier Mario Impiego di un estratto embrionale animale come sostanza nutriente e integratore dietetico-nutraceutico
ITMI20051572A1 (it) * 2005-08-12 2007-02-13 Alberto Astaldi Composizione farmaceutica contenente come sostanza attiva una frazione proteica estratta da embrioni di ovipari nel periodo del differenziamento cellulare e relativo processo di preparazione
ES2337537B8 (es) * 2008-03-19 2011-08-01 Joan Cunill Aixela Preparado alimenticio y composicion farmaceutica que contiene un extracto embrionario y sus respectivos usos.
WO2009146750A1 (en) * 2008-06-05 2009-12-10 Montco Cancer Research B.V. Anti-cancer immune-modulating agent
IT1400147B1 (it) * 2010-03-16 2013-05-17 Univ Roma Uso di un campo morfogenetico per la reversione del fenotipo di cellule tumorali
RO128485A0 (ro) 2012-09-19 2013-06-28 Hipocrate 2002 Serv S.R.L. Compoziţie cu biodisponibilitate crescută a embrio-peptidelor administrate oral şi procedeu de obţinere
US9750773B2 (en) * 2014-08-07 2017-09-05 Michele BIAVA Factors extracted from fish embryos and use of mixtures thereof in the control of stem cell multiplication and differentiation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451193A1 (fr) * 1979-03-13 1980-10-10 Brunel Henri Procede pour le traitement du cancer et preparation des produits employes pour ce traitement
DE4400640A1 (de) * 1994-01-12 1995-07-13 Eftag Entstaubung Foerdertech Verwendung von, Mittel mit und Verfahren zur Herstellung eines Arzneimittels mit Embryonalgewebe

Also Published As

Publication number Publication date
DE69714856T2 (de) 2003-05-22
WO1998011905A1 (en) 1998-03-26
ATE222499T1 (de) 2002-09-15
EP0929308B1 (en) 2002-08-21
AU3258097A (en) 1998-04-14
ITMI961945A1 (it) 1998-03-20
DE69714856D1 (de) 2002-09-26
EP0929308A1 (en) 1999-07-21
IT1284571B1 (it) 1998-05-21

Similar Documents

Publication Publication Date Title
MX9300298A (es) Conjugados de tioeter y procedimiento para su preparacion
AR027060A1 (es) Bases de mannich de 1-naftol y 2-naftol sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos, asi como el uso deestos compuestos para la fabricacion de medicamentos
ATE106730T1 (de) Antigestagen- und antiöstrogenwirksame verbindungen zur behandlung hormonabhängiger tumoren.
FI830100A0 (fi) Nya 6-substituerade s-triazolo /3,4-a/ ftalazinderivat
AR034699A1 (es) Procedimiento para la preparacion de moduladores del receptor glucocorticoide no esteroideos y compuestos intermediarios
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
AU3258097A (en) Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process
NL188284C (nl) Werkwijze voor de bereiding van alfa, beta-onverzadigde n-gesubstitueerde carbonzuuramiden.
PT1194415E (pt) Novos derivados da piperazinil-alquil-tiopirimidina composicoes farmaceuticas que os contem e um processo de preparacao da substancia activa
ES525574A0 (es) Procedimiento para producir preparaciones farmaceuticas que contienen como substancias activas derivados de polialquilenglicol.
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
DE60005952D1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
GT199900062A (es) Preparados efervescentes.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
FR2441617A1 (fr) Nouveaux derives de s-triazine, leur procede de preparation et compositions pharmaceutiques les contenant
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
ES2084585T3 (es) Derivados de la 6-oxo-piridazina, procedimiento para su obtencion y medicamentos que contienen estos compuestos.
ES2086026T3 (es) Farmaco con efecto antineoplasico que contiene como sustancia activa (2-(n-metil-piperidino)-etil)-fosfato de octadecilo y procedimiento para su preparacion.
ES2053679T3 (es) Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.
BR0016781A (pt) Bases de 1-naftol e 2-naftol - mannich substituìdas
SE7906440L (sv) Pyridoxinderivat samt forfarande for framstellning av dem
DE69822861D1 (de) Bentzothiophene
JPS5399314A (en) Therapeutic agent for nephritis
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa